| Jiang, Bo |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT05181137 / 2021-001940-86: A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis |
|
|
| Recruiting | 3 | 368 | Europe, US, RoW | SHR0302, Placebo | Reistone Biopharma Company Limited, Reistone Biopharma Company Limited | Ulcerative Colitis | 10/24 | 03/25 | | |
NCT06206174: TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies |
|
|
| Recruiting | 1/2 | 30 | RoW | TGRX-814, TGRX-814 monotherapy | Shenzhen TargetRx, Inc., Institute of Hematology & Blood Diseases Hospital, China | Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Adult, Myelodysplastic Syndromes | 02/25 | 02/29 | | |
NCT04322006: A Phase I/II Study of TJ004309 for Advanced Solid Tumor |
|
|
| Active, not recruiting | 1/2 | 376 | RoW | TJ004309, Toripalimab | TJ Biopharma Co., Ltd. | Advanced Solid Tumor | 12/24 | 12/24 | | |
NCT05380427: A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects |
|
|
| Completed | 1 | 80 | RoW | CU-40101 | Cutia Therapeutics（Wuxi）Co.,Ltd | AGA | 11/23 | 02/24 | | |
HRS-7249-101, NCT06541457: A Study on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7249 Injection in Healthy Subjects |
|
|
| Recruiting | 1 | 48 | RoW | HRS-7249 injection, Placebo | Fujian Shengdi Pharmaceutical Co., Ltd. | Hyperlipidemia | 05/25 | 05/25 | | |
NCT04872491: A Study of Vedolizumab in Adults in Real-World Practice |
|
|
| Completed | N/A | 500 | RoW | | Takeda | Colitis, Ulcerative, Crohn Disease | 07/24 | 07/24 | | |
| Xue, Jing |
NCT04981145: The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome |
|
|
| Recruiting | 4 | 78 | RoW | Iguratimod Tablets, Hydroxychloroquine Sulfate Tablets | Second Affiliated Hospital, School of Medicine, Zhejiang University | Primary Sjögren's Syndrome | 12/24 | 07/25 | | |
NCT04127747: Efficacy of Individualized Rituximab in Maintaining Remission of Moderate and Severe Systemic Lupus Erythematosus |
|
|
| Recruiting | 4 | 110 | RoW | Standard dose of rituximab, Individualized dose of rituximab | Second Affiliated Hospital, School of Medicine, Zhejiang University | Autoimmune Diseases | 12/22 | 07/23 | | |
BEconneCTD-ILD, NCT06572384: A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease |
|
|
| Recruiting | 3 | 440 | Europe, Japan, US, RoW | Belimumab, BENLYSTA, GSK1550188, Placebo | GlaxoSmithKline | Lung Diseases, Interstitial | 10/28 | 12/28 | | |
NCT06375005: Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis |
|
|
| Not yet recruiting | 2 | 38 | RoW | Telitacicept, Taiai for commercial name, Mycophenolate Mofetil, MMF | Second Affiliated Hospital, School of Medicine, Zhejiang University | Diffuse Cutaneous Systemic Sclerosis | 08/25 | 12/26 | | |
NCT05872724: Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease) |
|
|
| Recruiting | 2 | 32 | RoW | Chemoradiotherapy + Adjuvant chemotherapy and Zimberelimab, Chemoradiotherapy (small pelvic) + Zimberelimab | Suzhou Municipal Hospital | Cervical Cancer | 01/28 | 12/28 | | |
NCT06614270: Anti-CD19 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases |
|
|
| Recruiting | N/A | 15 | RoW | anti-CD19 CAR-NK cells | Second Affiliated Hospital, School of Medicine, Zhejiang University | Systemic Sclerosis (SSc), ANCA Associated Vasculitis (AAV), Idiopathic Inflammatory Myopathy (IIM), Sjogren's Syndrome, Antiphospholipid Syndrome | 01/26 | 01/27 | | |
| Recruiting | N/A | 2000 | RoW | | Peking Union Medical College Hospital | Anti Phospholipid Syndrome | 12/26 | 12/26 | | |
NCT04923074: the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis |
|
|
| Recruiting | N/A | 50 | RoW | diffusion tensor imaging(DTI) evaluation | Second Affiliated Hospital, School of Medicine, Zhejiang University | ANCA Associated Vasculitis | 07/23 | 07/23 | | |
